QT
TVTX icon

Quantbot Technologies’s Travere Therapeutics TVTX Stock Holding History

Quantbot Technologies’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$894 – 2007
2023
Q3 		$894 Buy
+100
New +$1.41K ﹤0.01% 1476
2023
Q2 		– Sell
-16,700
Closed -$376K – 1967
2023
Q1 		$376K Buy
+16,700
New +$355K 0.03% 706
2022
Q3 		– Sell
-6,500
Closed -$157K – 2110
2022
Q2 		$157K Buy
+6,500
New +$163K 0.01% 1010
2022
Q1 		– Sell
-341
Closed -$10K – 2058
2021
Q4 		$10K Buy
+341
New +$9.6K ﹤0.01% 1313
2021
Q3 		– Sell
-887
Closed -$12K – 1913
2021
Q2 		$12K Buy
+887
New +$17.5K ﹤0.01% 1294
2019
Q4 		– Sell
-1,250
Closed -$14K – 1599
2019
Q3 		$14K Buy
1,250
+950
+317% +$15.7K ﹤0.01% 1148
2019
Q2 		$6K Buy
+300
New +$5.92K ﹤0.01% 1118
2018
Q3 		– Sell
-2,870
Closed -$78K – 1556
2018
Q2 		$78K Sell
2,870
-2,088
-42% -$55.6K 0.01% 919
2018
Q1 		$110K Buy
+4,958
New +$118K 0.01% 823
2017
Q4 		– Sell
-2,683
Closed -$66K – 1492
2017
Q3 		$66K Buy
+2,683
New +$59.1K 0.01% 920
2017
Q2 		– Sell
-3,355
Closed -$61K – 1392
2017
Q1 		$61K Sell
3,355
-2,258
-40% -$44.2K 0.01% 883
2016
Q4 		$106K Buy
5,613
+1,790
+47% +$36.6K 0.01% 700
2016
Q3 		$85K Buy
3,823
+713
+23% +$13.6K 0.01% 753
2016
Q2 		$55K Sell
3,110
-726
-19% -$11.8K 0.01% 815
2016
Q1 		$52K Buy
+3,836
New +$58.2K 0.01% 863
2015
Q4 		– Sell
-500
Closed -$10K – 1377
2015
Q3 		$10K Sell
500
-400
-44% -$11.8K ﹤0.01% 1087
2015
Q2 		$29K Buy
+900
New +$24.6K 0.01% 901
2015
Q1 		– Sell
-200
Closed -$2K – 1359
2014
Q4 		$2K Buy
+200
New +$2.07K ﹤0.01% 1066

Other funds holding TVTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Quantbot Technologies's TVTX Position: Q4 2023 in Review

Quantbot Technologies sold out of Travere Therapeutics (TVTX) in Q4 2023, closing a stake of 100 shares — an estimated $894 sold.

Quantbot Technologies first reported a position in TVTX in Q4 2014 and held it in 18 quarters. The position peaked at $376K in Q1 2023. 165 funds tracked by Wall St. Rank hold TVTX as of Q4 2023.

  • Quantbot Technologies reported no remaining Travere Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 100 Travere Therapeutics shares in Q4 2023, an estimated $894.
  • Quantbot Technologies first reported a position in Travere Therapeutics in Q4 2014 and held it in 18 quarters.
  • Quantbot Technologies's Travere Therapeutics position peaked at $376K in Q1 2023.
  • 165 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.